Sitaxa Gm Ir 50/1/1000 Tab

SITAXA GM IR 50/1/1000 TAB

SITAXA GM IR 50/1/1000 TAB is a fixed-dose combination medication manufactured by Torrent Pharmaceuticals Ltd, designed for the comprehensive management of Type 2 Diabetes Mellitus.

Composition Each tablet contains:

• Sitagliptin Phosphate: 50 mg
• Glimepiride: 1 mg
• Metformin: 1000 mg

Uses SITAXA GM IR 50/1/1000 TAB is prescribed for adults with Type 2 Diabetes Mellitus to:

• Control and lower high blood sugar levels.
• Improve overall glycemic control.
• Serve as an adjunct therapy when diet and exercise alone, or with other blood sugar-lowering medicines, are insufficient.
• Reduce the risk of long-term diabetes-related complications such as nerve damage, kidney problems, blindness, limb amputations, and heart diseases like heart attack or stroke.

Dosage and Administration

• Take SITAXA GM IR 50/1/1000 TAB orally with food, typically with the first meal of the day, or as directed by your doctor.
• Swallow the tablet whole with a glass of water; do not crush, break, or chew it.
• Adhere strictly to the prescribed dosage and frequency. Do not alter the dose or discontinue the medicine without consulting your healthcare provider.
• If a dose is missed, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and continue your regular schedule. Do not take a double dose to compensate.
• Regular monitoring of blood sugar levels is crucial during treatment.

Side Effects Common side effects may include:

• Headache
• Diarrhea, nausea, vomiting, abdominal discomfort/pain, upset stomach
• Hypoglycemia (low blood sugar), which can cause symptoms like sweating, shakiness, confusion, anger, and a fast heartbeat.
• Weight gain
• Upper respiratory tract infections, runny nose, sore throat
• Musculoskeletal pain
• Frequent urination

Serious side effects, though rare, warrant immediate medical attention. These include signs of a severe allergic reaction (wheezing, chest tightness, fever, itching, seizures, swelling of face, lips, tongue, or throat), signs of infection, or symptoms of lactic acidosis (e.g., muscle pain, weakness, dizziness, extreme weakness).

Precautions

• Allergies: Do not take this medicine if you are allergic to any of its components or have a sulfa (sulfonamide) allergy.
• Pregnancy: SITAXA GM IR 50/1/1000 TAB may not be recommended during pregnancy (Pregnancy Category C); consult your doctor for advice.
• Breastfeeding: Consult your doctor before using this medicine while breastfeeding, as it is probably unsafe.
• Alcohol: Limit or avoid alcohol consumption, as it can affect blood sugar control and increase the risk of hypoglycemia and lactic acidosis.
• Kidney/Liver Impairment: Use with caution in patients with kidney or liver problems. It is not recommended for severe kidney or liver disease due to an increased risk of lactic acidosis. Regular monitoring and dose adjustments may be necessary.
• Children and Elderly: This medicine is generally not recommended for children under 18 years of age. Elderly patients may require dose adjustments due to increased sensitivity and higher risk of low blood sugar.
• Drug Interactions: Inform your doctor about all prescription and over-the-counter medications, as well as herbal supplements you are taking, to avoid potential drug interactions.
• Other Conditions: This medication is not for Type 1 diabetes, acute or chronic metabolic acidosis (including diabetic ketoacidosis), or patients with active bladder cancer or a history of bladder cancer. Use with caution in patients with heart failure.
• Hypoglycemia: Always carry a source of sugar (e.g., hard candies, glucose tablets, fruit juice) to treat symptoms of low blood sugar.

Storage

• Store SITAXA GM IR 50/1/1000 TAB at room temperature, ideally between 20-25°C or below 30°C.
• Protect from moisture and light; keep in a dry place.
• Keep out of the reach of children.
• Do not use the medicine after its expiry date.

What is SITAXA GM IR 50/1/1000 TAB used for?

SITAXA GM IR 50/1/1000 TAB is a fixed-dose combination medication primarily used for the management of type 2 diabetes mellitus in adults. It helps to control high blood sugar levels, improve glycemic control, and reduce the risk of diabetes-related complications such as nerve damage, kidney problems, blindness, and heart issues. This medicine is typically prescribed when diet and exercise alone or other single or dual therapies are not sufficient to achieve adequate blood sugar control.

How does SITAXA GM IR 50/1/1000 TAB work?

SITAXA GM IR 50/1/1000 TAB combines three active ingredients: Sitagliptin, Metformin, and Glimepiride, each working through different mechanisms to lower blood glucose. Sitagliptin, a DPP-4 inhibitor, increases the levels of natural hormones (incretins) that enhance insulin release from the pancreas and decrease glucagon levels in a glucose-dependent manner. Metformin, a biguanide, reduces glucose production by the liver, decreases the absorption of glucose from the intestines, and improves insulin sensitivity in the body's tissues. Glimepiride, a sulfonylurea, stimulates the beta cells in the pancreas to produce and release more insulin.

What is the usual dosage for SITAXA GM IR 50/1/1000 TAB?

The dosage of SITAXA GM IR 50/1/1000 TAB should be taken exactly as prescribed by your doctor. It is typically taken orally with food, often with the first meal of the day or an evening meal, to help reduce the risk of gastrointestinal side effects and maintain stable blood sugar levels. Do not change the dose or stop the medication without consulting your healthcare provider.

What are the possible side effects of SITAXA GM IR 50/1/1000 TAB?

Common side effects may include hypoglycemia (low blood sugar), nausea, vomiting, diarrhea, abdominal discomfort, headache, upper respiratory tract infections, and musculoskeletal pain. Signs of low blood sugar include anger, shaking, a fast heartbeat, confusion, or sweating. If you experience severe side effects or if common side effects persist or worsen, contact your doctor immediately.

Is SITAXA GM IR 50/1/1000 TAB safe during pregnancy or breastfeeding?

SITAXA GM IR 50/1/1000 TAB may not be recommended during pregnancy and is generally not recommended during breastfeeding. It is crucial to consult your doctor for advice on appropriate diabetes treatment if you are pregnant, planning pregnancy, or breastfeeding, to assess potential risks and benefits.

Can SITAXA GM IR 50/1/1000 TAB be taken with other medications?

There are potential drug interactions with SITAXA GM IR 50/1/1000 TAB. It is important to inform your doctor about all medications you are currently taking, including prescription drugs, over-the-counter medicines, and herbal supplements, to avoid any adverse effects. Some medications, such as corticosteroids, calcium channel blockers, and sympathomimetics, may affect the blood sugar-lowering effect of this medicine.

What precautions should be taken while using SITAXA GM IR 50/1/1000 TAB?

Avoid or limit alcohol intake while taking SITAXA GM IR 50/1/1000 TAB, as it can increase the risk of hypoglycemia (low blood sugar) and lactic acidosis (a rare but serious condition). Use this medication with caution if you have liver or kidney impairment, as regular monitoring may be required to adjust the dosage. Inform your doctor if you have a sulfa (sulfonamide) allergy or type 1 diabetes. Regular monitoring of blood sugar levels is crucial.

What happens if a dose of SITAXA GM IR 50/1/1000 TAB is missed?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double dose to make up for a missed dose.

How should SITAXA GM IR 50/1/1000 TAB be stored?

SITAXA GM IR 50/1/1000 TAB should be stored at room temperature, typically between 20-25°C or below 30°C. Protect it from moisture and light, and keep it in a dry place. Always keep the medicine out of the reach of children.